GO:0006021 inositol biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006021 (inositol biosynthetic process) describes the chemical reactions and pathways that form inositol, 1,2,3,4,5,6-cyclohexanehexol, a growth factor for animals and microorganisms.
• The pathway is best known through the conserved enzyme inositol-3-phosphate synthase (ISYNA1/INO1), which converts glucose-6-phosphate to inositol-3-phosphate, followed by dephosphorylation to free myo-inositol.
• Inositol and its phosphorylated derivatives are central to cell signaling, osmolyte balance, membrane biogenesis, and protein trafficking.
• Inositol polyphosphates influence diverse cellular processes, including prion propagation in yeast, highlighting deep evolutionary conservation.
• Microbial and engineered systems are increasingly used for sustainable inositol production, with relevance to nutrition and biotechnology.
• Inositol metabolism is clinically relevant in polycystic ovary syndrome (PCOS), where inositol supplementation can improve endocrine and metabolic profiles.
Description
Inositol biosynthetic process (GO:0006021) is the set of biochemical reactions that produce inositol, a six-carbon cyclitol that serves as a growth factor for animals and microorganisms. In cells, inositol is not only a building block for phosphoinositides and inositol polyphosphates but also an important osmolyte and signaling precursor. The pathway is therefore positioned at the intersection of metabolism, signal transduction, and membrane biology. Researchers study GO:0006021 because its products influence hormone signaling, stress responses, and metabolic disease, and because the pathway is conserved from yeast to humans. The canonical route begins with glucose-6-phosphate and proceeds through inositol-3-phosphate to free myo-inositol, with additional diversity in microbial and plant systems. Understanding this process helps explain how cells maintain inositol pools and how perturbations contribute to disease.
inositol biosynthetic process At A Glance
| GO ID | GO:0006021 |
|---|---|
| GO term | inositol biosynthetic process |
| Ontology | biological_process |
| Synonym | inositol anabolism; inositol biosynthesis; inositol formation; inositol synthesis; myo-inositol biosynthesis; myo-inositol biosynthetic process; vitamin Bh biosynthesis; vitamin Bh biosynthetic process |
| Major function | Formation of inositol, a growth factor and precursor for phosphoinositides and inositol polyphosphates |
| Key enzyme | Inositol-3-phosphate synthase (ISYNA1/INO1) catalyzes the committed step from glucose-6-phosphate |
| Cellular context | Cytosol and membrane-associated compartments; supports osmolyte balance and signaling |
| Organismal relevance | Conserved from yeast to humans; important in metabolism, development, and stress responses |
| Disease links | PCOS and metabolic disorders; inositol derivatives implicated in cancer signaling and neurodegeneration |
What Is GO:0006021?
GO:0006021, inositol biosynthetic process, is defined by QuickGO as the chemical reactions and pathways resulting in the formation of inositol, 1,2,3,4,5,6-cyclohexanehexol, a growth factor for animals and microorganisms. In practical terms, it covers the enzymatic steps that convert simple sugar phosphates into inositol and its phosphorylated intermediates, as well as the regulatory and transport processes that support inositol accumulation.
Why Is inositol biosynthetic process Important in Cell Biology?
GO:0006021 matters because inositol is a growth factor and a precursor to signaling molecules that regulate cell growth, metabolism, and stress responses. The pathway supplies myo-inositol for phosphoinositide synthesis and inositol polyphosphate signaling, which influence membrane trafficking, ion channels, and nuclear processes. In microorganisms, inositol biosynthesis supports osmotolerance and viability, and in yeast it intersects with prion propagation. In humans, inositol status is linked to insulin sensitivity and reproductive endocrinology, as shown by trials in PCOS. Biotechnologically, microbial and engineered inositol production is an active area for sustainable manufacturing.
• Provides myo-inositol, a growth factor required by animals and microorganisms.
• Supplies precursors for phosphoinositides and inositol polyphosphates involved in signal transduction.
• Supports osmotic balance and stress tolerance in microbial and plant cells.
• Contributes to membrane biogenesis and protein trafficking through phosphoinositide pools.
• Influences prion propagation in yeast, linking inositol polyphosphates to protein conformational states.
• Has clinical relevance in PCOS, where inositol supplementation improves endocrine and metabolic parameters.
• Is a target for metabolic engineering to produce inositol sustainably.
• Helps explain the evolutionary conservation of inositol-dependent signaling across eukaryotes.
• Provides a model for studying enzyme catalysis and metabolic channeling in central metabolism.
• Connects to cancer biology through inositol polyphosphate signaling pathways.
What Happens During inositol biosynthetic process?
Conversion of glucose-6-phosphate to inositol-3-phosphate
In simple terms: The cell takes a sugar phosphate and rearranges it into a ring-shaped molecule called inositol-3-phosphate.
The committed step of inositol biosynthesis is catalyzed by inositol-3-phosphate synthase (ISYNA1 in humans, INO1 in yeast), which converts glucose-6-phosphate to inositol-3-phosphate. This enzyme is conserved and represents the primary route for de novo inositol synthesis in many organisms. The reaction is rate-limiting and is subject to regulation at the transcriptional and post-transcriptional levels.
Dephosphorylation to free myo-inositol
In simple terms: A phosphate group is removed to release the usable form of inositol.
Inositol-3-phosphate is dephosphorylated by specific phosphatases to yield free myo-inositol, the form used in most cellular functions. This step is important for maintaining the pool of free inositol available for phosphoinositide synthesis and osmolyte functions. The balance between phosphorylated and free inositol is critical for normal cell physiology.
Transport and compartmentalization of inositol
In simple terms: Inositol must be moved into the right parts of the cell to do its jobs.
Inositol transport proteins mediate the uptake and distribution of inositol across membranes, influencing intracellular pools and signaling. Proper compartmentalization supports phosphoinositide synthesis at membranes and inositol polyphosphate signaling in the cytosol and nucleus. Transport is therefore an integral part of the functional inositol biosynthetic process.
Integration with inositol polyphosphate signaling
In simple terms: Inositol can be further modified into signaling molecules that control many cell processes.
Inositol serves as a precursor for inositol polyphosphates, which act as signaling molecules in diverse pathways including chromatin regulation and vesicle trafficking. In yeast, inositol polyphosphates influence prion propagation, demonstrating a link between inositol biosynthesis and protein-based inheritance. These connections show that GO:0006021 is not an isolated metabolic pathway but a hub for cellular regulation.
Microbial and biotechnological synthesis
In simple terms: Microbes and engineered cells can be used to make inositol on a large scale.
Microbial synthesis of health-promoting inositols is an active area of biotechnology, leveraging native or engineered pathways. Recent advances in myo-inositol production highlight the potential for sustainable manufacturing to meet nutritional and pharmaceutical demand. These efforts build on the same core enzymatic steps defined in GO:0006021.
Key Genes Involved in GO:0006021 inositol biosynthetic process
The following genes and proteins are central to inositol biosynthetic process (GO:0006021) and are commonly studied in metabolic, signaling, and biotechnological research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ISYNA1 | Inositol-3-phosphate synthase; catalyzes the committed step in myo-inositol synthesis | Key target for studying de novo inositol production and metabolic regulation |
| INO1 | Yeast inositol-3-phosphate synthase; model enzyme for pathway regulation | Used to dissect transcriptional and metabolic control of inositol biosynthesis |
| IMPase | Inositol monophosphatase; dephosphorylates inositol-3-phosphate to free inositol | Important for understanding inositol pool maintenance and lithium action |
| ITPK1 | Inositol-tetrakisphosphate 1-kinase; involved in inositol polyphosphate metabolism | Links inositol biosynthesis to signaling and chromatin regulation |
| IPMK | Inositol polyphosphate multikinase; generates higher inositol polyphosphates | Studied for roles in nuclear signaling and cell growth |
| PLC | Phospholipase C; hydrolyzes phosphoinositides to generate signaling molecules | Connects inositol lipids to calcium signaling and downstream pathways |
| PIK | Phosphatidylinositol kinases; synthesize phosphoinositides from inositol | Critical for membrane trafficking and signal transduction |
| SLC5A3 | Sodium/myo-inositol cotransporter; mediates inositol uptake | Relevant to osmolyte regulation and inositol transport studies |
| SMIT1 | Sodium/myo-inositol cotransporter 1; transports inositol in brain and other tissues | Studied in osmotic stress and neurological contexts |
| HMIT | H+/myo-inositol symporter; regulates inositol uptake in neurons | Linked to brain inositol homeostasis and signaling |
| MIPS | Myo-inositol-1-phosphate synthase in plants and microbes | Target for crop and microbial engineering of inositol |
| IPK1 | Inositol polyphosphate kinase; modifies inositol polyphosphates | Involved in signaling and stress responses |
| IP6K | Inositol hexakisphosphate kinase; produces inositol pyrophosphates | Studied in energy metabolism and signaling |
| PPIP5K | Diphosphoinositol pentakisphosphate kinase; generates inositol pyrophosphates | Relevant to cellular stress and metabolic regulation |
| Vip1 | Yeast inositol pyrophosphate synthase; model for inositol polyphosphate function | Used to study prion propagation and signaling |
| Kcs1 | Yeast inositol pyrophosphate kinase; affects stress responses | Model for inositol polyphosphate roles in cell physiology |
| GIT1 | Glycerophosphoinositol inositol monophosphatase; affects inositol metabolism | Studied in yeast metabolic regulation |
| Opi1 | Yeast transcriptional repressor regulated by inositol metabolites | Key regulator of INO1 expression and inositol biosynthesis |
How Is inositol biosynthetic process Regulated?
Inositol biosynthetic process is regulated at multiple levels. In yeast, the transcription factor Opi1 represses INO1 in response to inositol availability, linking pathway activity to lipid and metabolite signals. In mammalian cells, ISYNA1 expression and activity are influenced by metabolic status and stress, though the precise mechanisms are still being defined. Inositol transport proteins also modulate intracellular inositol pools, adding a layer of regulation independent of synthesis. Inositol polyphosphates can feedback into signaling pathways that affect cell growth and metabolism, indirectly influencing inositol demand.
inositol biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ISYNA1 | PCOS and metabolic disorders; inositol availability | Knockout or overexpression in ovarian or metabolic cell lines |
| ITPK1 | Cancer signaling via inositol polyphosphates | Point mutation or knockout in cancer cell lines |
| IPMK | Nuclear signaling and cell growth | Knockout and rescue in mammalian cells |
| SLC5A3 | Osmotic stress and neurological function | Knockdown or knockout in neuronal models |
| Vip1 | Prion propagation in yeast | Yeast knockout and prion propagation assays |
Inositol biosynthesis and polycystic ovary syndrome (PCOS)
Inositol supplementation has been evaluated in women with PCOS, where it can improve endocrine and metabolic profiles, including insulin sensitivity and ovulation-related parameters. These clinical observations highlight the importance of inositol availability and metabolism in reproductive and metabolic health. Research into GO:0006021 helps explain how endogenous inositol production and transport contribute to these effects.
Inositol polyphosphates in cancer signaling
Inositol polyphosphates generated downstream of inositol biosynthesis participate in signaling pathways that regulate cell growth, survival, and gene expression. Dysregulation of these pathways has been implicated in cancer biology, making inositol metabolism a subject of interest for understanding tumor cell signaling. Targeting inositol polyphosphate enzymes is an area of preclinical investigation.
Inositol metabolism and neurodegeneration
Inositol transport and homeostasis are important in the nervous system, where inositol serves as an osmolyte and signaling precursor. Alterations in inositol metabolism have been linked to neurological conditions, though the exact mechanisms remain under study. The conserved roles of inositol derivatives in membrane trafficking and signaling suggest broad relevance to neuronal function.
Microbial inositol biosynthesis and prion biology
In yeast, inositol polyphosphates influence prion propagation, connecting inositol biosynthesis to protein conformational inheritance. This model system has provided insights into how inositol metabolites affect protein aggregation and cellular stress responses. Such findings underscore the evolutionary depth of inositol-dependent regulation.
From inositol biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ISYNA1 reduce de novo inositol synthesis? | ISYNA1 knockout cell line with metabolic profiling |
| How do point mutations in ISYNA1 affect enzyme activity? | Point-mutation knock-in of catalytic residues |
| Can tagged ISYNA1 reveal subcellular localization? | Tagged knock-in (e.g., GFP) in mammalian cells |
| Does overexpression of inositol transporters increase inositol uptake? | Overexpression of SLC5A3 or SMIT1 in cell lines |
| Which genes regulate INO1 expression in yeast? | Yeast knockout library and transcriptional reporters |
| How does inositol polyphosphate signaling affect prion propagation? | Yeast mutants with altered inositol polyphosphate enzymes |
How to Study the inositol biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Levels of inositol and inositol phosphates | Quantifying pathway output in cells and tissues |
| Isotope tracing | Flux from glucose to inositol | Assessing de novo synthesis rates |
| RNA-seq | Expression of ISYNA1, INO1, transporters | Identifying transcriptional regulation |
| Proteomics | Protein abundance and modifications | Detecting pathway enzyme regulation |
| Enzyme activity assay | Catalytic activity of ISYNA1/IMPase | Characterizing mutations and inhibitors |
| Fluorescence microscopy | Subcellular localization of tagged proteins | Studying compartmentalization |
| Yeast genetics | Growth and prion propagation phenotypes | Modeling inositol polyphosphate functions |
| CRISPR screening | Genes affecting inositol dependence | Identifying synthetic lethal interactions |
Metabolic profiling and isotope tracing
Mass spectrometry-based metabolomics and isotope tracing can quantify inositol and its phosphorylated intermediates, revealing flux through GO:0006021. These methods are essential for assessing how genetic or environmental changes alter inositol production.
Transcriptional and proteomic analysis
RNA-seq and proteomics can measure expression of inositol biosynthetic enzymes and transporters, identifying regulatory mechanisms. Such approaches help link pathway activity to cellular states and disease models.
Enzymatic assays
In vitro assays with purified ISYNA1 or IMPase can determine catalytic parameters and the impact of mutations. These assays are foundational for mechanistic studies of the pathway.
Imaging and subcellular localization
Fluorescent tagging of inositol biosynthetic enzymes and transporters allows visualization of their localization and dynamics. Imaging can reveal how inositol metabolism is compartmentalized.
How CRISPR Can Be Used to Study GO:0006021 inositol biosynthetic process
Knockout
CRISPR knockout of ISYNA1 or INO1 can abolish de novo inositol synthesis, allowing researchers to test reliance on exogenous inositol and downstream signaling. Knockout of transporters such as SLC5A3 can reveal their contribution to inositol uptake and osmotic balance.
Point Mutation
Introducing point mutations in catalytic residues of ISYNA1 or IMPase can dissect enzyme mechanism and identify separation-of-function variants. Such models are valuable for linking specific activities to cellular phenotypes.
Knock-in
Tagged knock-in of inositol biosynthetic enzymes enables real-time tracking of localization and interactions without overexpression artifacts. Knock-in of disease-associated variants can model human metabolic phenotypes.
Overexpression
Overexpression of ISYNA1 or inositol transporters can increase inositol pools and test sufficiency for signaling or metabolic outcomes. This approach is also used in biotechnological strains for enhanced inositol production.
How EDITGENE Supports inositol biosynthetic process Research
Researchers studying inositol biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in metabolite production, signaling, or disease phenotypes. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations to answer these questions.
Contact EDITGENE today to design your custom CRISPR model for inositol biosynthetic process research.
Frequently Asked Questions About inositol biosynthetic process
What is inositol biosynthetic process (GO:0006021)?
It is the set of biochemical reactions that produce inositol, a growth factor and signaling precursor, as defined by QuickGO.
What genes are involved in inositol biosynthetic process?
Key genes include ISYNA1, INO1, IMPase, and inositol transporters such as SLC5A3 and SMIT1.
What is the main enzyme in inositol biosynthesis?
Inositol-3-phosphate synthase (ISYNA1/INO1) catalyzes the committed step from glucose-6-phosphate to inositol-3-phosphate.
How is inositol biosynthetic process regulated?
It is regulated transcriptionally, for example by Opi1 in yeast, and by metabolite feedback and transport activity.
Why is inositol important for cells?
Inositol is a precursor for phosphoinositides and inositol polyphosphates that regulate signaling, membrane trafficking, and osmolyte balance.
Is inositol biosynthesis linked to PCOS?
Yes, inositol supplementation has been shown to improve endocrine and metabolic profiles in women with PCOS.
Can CRISPR be used to study inositol biosynthesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can dissect gene function in this pathway.
What diseases are associated with inositol metabolism?
PCOS, cancer signaling, and neurological conditions have been linked to inositol metabolism and signaling.
How do researchers measure inositol biosynthesis?
Metabolomics, isotope tracing, enzyme assays, and transcriptomics are commonly used.
What is the role of inositol polyphosphates?
They act as signaling molecules influencing processes such as chromatin regulation, vesicle trafficking, and prion propagation.
Conclusion
GO:0006021 (inositol biosynthetic process) is a conserved metabolic pathway that produces a molecule essential for signaling, osmotic balance, and membrane biology. Its core enzymes, especially ISYNA1/INO1, are well-characterized and serve as entry points for mechanistic and translational studies. The pathway connects to human health through conditions such as PCOS and to biotechnology through microbial inositol production. Continued research using CRISPR models and metabolic profiling will further clarify how inositol biosynthesis is regulated and how it can be targeted therapeutically.
References
- 1. Zhao H et al.. 2021. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.. Reprod Health 18(1):171 PMID: 34407851
- 2. Schneider S. 2015. Inositol transport proteins.. FEBS Lett 589(10):1049-58 PMID: 25819438
- 3. Yoshida KI et al.. 2024. Microbial synthesis of health-promoting inositols.. Curr Opin Biotechnol 87:103114 PMID: 38520822
- 4. Maffucci T et al.. 2020. Signalling Properties of Inositol Polyphosphates.. Molecules 25(22) PMID: 33198256
- 5. Wickner RB et al.. 2018. Prion propagation and inositol polyphosphates.. Curr Genet 64(3):571-574 PMID: 29243174
- 6. Frej AD et al.. 2016. The Inositol-3-Phosphate Synthase Biosynthetic Enzyme Has Distinct Catalytic and Metabolic Roles.. Mol Cell Biol 36(10):1464-79 PMID: 26951199
- 7. Li Y et al.. 2022. Production of myo-inositol: Recent advance and prospective.. Biotechnol Appl Biochem 69(3):1101-1111 PMID: 33977572
- 8. Michell RH. 2008. Inositol derivatives: evolution and functions.. Nat Rev Mol Cell Biol 9(2):151-61 PMID: 18216771
